Expanding their global perspective and markets, TKL Research is pleased to announce the hiring of Jeffrey Bagshaw as VP of Global Business Development for the Clinical Trials Division on June 2, 2015. Bagshaw will be responsible for leading strategic corporate and business development efforts internationally.
TKL Research is a full-service clinical research organization serving the pharmaceutical, biotechnology, medical device and consumer healthcare industries internationally.
Bagshaw previously served as chief operating officer at Inclinix where he was responsible for leading global operations, strategic partnership development and clinical research services. During his tenure at Inclinix, he held various leadership roles in medical marketing and compliance, medical support services and business development.
In addition to Inclinix, Bagshaw has more than 25 years of experience in the pharmaceutical, biotechnology, medical device and applied genomic industries, and he has been responsible for the clinical development and marketing of products across numerous therapeutic areas. His experience includes leadership roles at Hoffmann-La Roche, Bristol-Myers Squibb and Exact Sciences.